Bone morphogenetic proteins in human bone regeneration

European Journal of Endocrinology

Volumn 142, Issue 1, 2000, Pages 9-21

  Groeneveld, E H J ^a   Burger, E H ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COLLAGEN; OSTEOGENIC PROTEIN 1; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA;

BIOCOMPATIBILITY; BONE DEFECT; BONE DEVELOPMENT; BONE GRAFT; BONE REGENERATION; HUMAN; MAXILLOFACIAL SURGERY; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; PRIORITY JOURNAL; REVIEW; TOOTH EXTRACTION;

EID: 0033975065     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420009     Document Type: Review

References (176)

1. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P et al. A feasibility study evaluating rhBMP-2/ absorbable collagen sponge for maxillary sinus floor augmentation. International Journal of Periodontics and Restorative Dentistry 1997 17 10-25.
2. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P Lazaro M, Lilly L, Cochran D et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. International Journal of Periodontics and Restorative Dentistry 1997 17 125-139.
3. Groeneveld HHJ, Van den Bergh JPA, Ten Bruggenkate CM, Tuinzing DB & Burger EH. Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralized bone matrix or autogenous bone. Comparison with non-grafted sites in a series of case reports. Clinical Oral Implants Research 1999 (In Press).
4. Geesink RGT, Hoefnagels NHM & Bulstra SK. Osteogenic activity of OP-1, bone morphogenetic protein-7 (BMP-7), in a human fibular defect model. Journal of Bone and Joint Surgery, British Volume 1999 81 710-718.
5. Urist MRl. Bone: formation by autoinduction. Science 1965 150 893-899.
6. Van de Putte KA & Urist MR. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix. Clinical Orthopaedics and Related Research 1965 257-270.
7. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS & Wozney JM. Purification and characterization of other distinct bone-inducing factors. Proceedings of the National Academy af Sciences of the USA 1988 85 9484-9488.
8. Sampath TK & Reddi AH. Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proceedings of the National Academy of Sciences of the USA 1983 80 6591-6595,
9. Wang EA. Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends In Biotechnology 1993 11 379-583.
10. Sasano Y, Ohtani E, Narita K, Kagayama M. Murata M, Saito T, Shigenobu K, Takita H, Mizuno M & Kuboki Y. BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo. Anatomical Record 1993 236 373-380.
11. Reddi AH & Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proceedings of the National Academy of Sciences of the USA 1972 69 1601-1605.
12. Reddi AH, Wientroub S & Muthukumaran N. Biologic principles of bone induction. Orthopedic Clinics of North America 1987 18 207-212.
13. Urist MR, Iwata H, Ceccotti PL, Dorfman RL, Boyd SD, McDowell RM & Chien C. Bone morphogenesis in implants of insoluble bone gelatin. Proceedings of the National Academy of Sciences of the USA 1973 70 3511-3515.
14. Tiedeman JJ, Connolly JF, Strates BS & Lippiello L, Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clinical Orthopaedics 1991 268 294-302.
15. Gepstein R, Weiss RE & Hallel T. Bridging large defects in bone by demineralized bone matrix in the form of a powder. A radiographic, histological, and radioisotope-uptake study in rats. Journal of Bone and Joint Surgery, American Volume 1987 69 984-992.
16. Gebhart M & Lane J. A radiographical and biomechanical study of demineralized bone matrix implanted into a bone defect of rat femurs with and without bone marrow. Acta Orthopaedica Belgica 1991 57 130-143.
17. Einhorn TA, Lane JM, Burstein AH, Kopman CR & Vigorita VJ. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. Journal of Bone and Joint Surgery, American Volume 1984 66 274-279.
18. Mohammadreza Y. Demineralized bone matrix in treatment of periodontal defects. A review of the literature. Journal of the Western Society of Periodontology Abstracts 1987 35 105-108.
19. Glowacki J. Kaban LB. Murray JE, Folkman J & Mulliken JB. Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet 1981 1 959-962.
20. Mulliken JB, Glowacki J, Kaban LB, Folkman J & Murray JE. Use of demineralized allogeneic bone implants for the correction of maxillocraniofacial deformities. Annals of Surgery 1981 194 366-372.
21. Kaban LB, Mulliken JB & Glowacki J. Treatment of jaw defects with demineralized bone implants. Journal of Oral Maxillofacial Surgery 1982 40 623-626.
22. Sonis ST, Kaban LB & Glowacki J. Clinical trial of demineralized bone powder in the treatment of periodontal defects. Journal of Oral Medicine 1983 38 117-122.
23. Becker W, Schenk R, Higuchi K, Lekholm U & Becker BE. Variations in bone regeneration adjacent to implants augmented with barrier membranes alone or with demineralized freeze-dried bone or autologous grafts: a study in dogs. International Journal of Oral and Maxillofacial Implants 1995 10 143-1 54.
24. Becker W, Lynch SE, Lekholm U, Becker BE, Caffesse R, Donath K & Sanchez R. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. Journal of Periodontology 1992 63 929-940.
25. Groeneveld HHJ, Van den Bergh JPA, Holzmann P, Ten Bruggenkate CM, Tuinzing DB & Burger EH. Mineralization processes in demineralized bone matrix grafts in sinus floor elevations. Journal of Biomedical Materials and Research 1999 48 393-402.
26. Becker W, Becker BE & Caffesse R. A comparison of demineralized freeze-dried bone and autologous bone to induce bone formation in human extraction sockets. Journal of Periodontology 1994 65 1128-1133.
27. Strates BS & Tiedeman JJ. Contribution of osteoinductive and osteoconductive properties of demineralized bone matrix to skeletal repair. European Journal of Experimental Musculoskeletal Research 1993 2 61-67.
28. Schwartz Z Melloning JT, Carnes Jr DL, De La Fontaine J. Cochran DD & Boyan BD. Ability of commercial demincralized freeze-dried bone allograft to induce new bone formation. Journal of Periodontology 1996 67 918-926.
29. Shigeyama Y, Derrico JA, Stone R & Somerman MJ. Commercially-prepaired allograft material has biological activity in vitro. Journal of Periodontology 1995 66 478-487.
30. Becker W, Urist MR, Tucker LM. Becker BK & Ochsenbein C. Human demineralized freeze-dried bone: inadequate induced bone formation in athymic mice. A preliminary report. Journal of Periodontology 1995 66 822-828.
31. Aspenberg P & Lindqvist SB. Ethene oxide and bone induction. Controversy remains. Acta Orthopaedica Scandinavica 1998 69 173-176.
32. Ripamonti U, Magan A, Ma S, van den Heever B. Moehl T & Reddi AH. Xenogeneic osteogenin, a bone morphogenetic protein, and demineralized bone matrices, including human, induce bone differentiation in athymic rats and baboons. Matrix 1991 11 404-411.
33. Huggins C, Wiseman S & Reddi AH. Transformation of Fibroblasts by allogeneic and xenogeneic transplants of demineralized tooth and bone. Journal of Experimental Medicine 1970 132 1250-1258.
34. Aspenberg P, Lohmander LS & Thorngren KG. Failure of bone induction by bone matrix in adult monkeys. Journal of Bone and Joint Surgery. British Volume 1988 70 625-627.
35. Hosny M & Sharawy M. Osteoinduction in rhesus monkeys using demineralized bone powder allografts. Journal of Oral and Maxillofacial Surgery 1985 43 837-844.
36. Aspenberg P, Wang E & Thorngren KG. Bone morphogenetic protein induces bone in the squirrel monkey, but bone matrix does not. Acta Orthopaedica Scandinavica 1992 63 619-622.
37. Ripamonti U, Ma S. Cunningham NS, Yeates L & Reddi AH. Initiation of bone regeneration in adult baboons by osteogenin. a bone morphogenetic protein. Matrix 1992 12 369-380.
38. Johnson EE, Urist MR & Finerman GA. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clinical Orthopaedics and Related Research 1988 230 257-265.
39. Johnson EE, Urist MR & Finerman GA. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clinical Orthopaedics and Related Research 1988 236 249-257.
40. Johnson EE. Urist MR & Finerman GA. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clinical Orthopaedics and Related Research 1990 250 234-240.
41. Johnson EE, Urist MR & Finerman GA. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clinical Orthopaedics and Related Research 1992 277 229-237.
42. Johnson EE & Urist MR. One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein. Clinical Orthopaedics and Related Research 1998 347 105-116.
43. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM & Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988 242 1528-1534.
44. Massague J. The transforming growth factor-beta family. Annual Review of Cell Biology 1990 6 597-541.
45. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms, Gender and Development 1994 8 133-146.
46. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature Biotechnology 1998 16 247-252.
47. Wozney JM. Bone morphogenetic proteins. Progress in Growth Factor Research 1989 1 267-280.
48. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V. Wang EA & Wozney JM. Identitication of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proceedings of the National Academy of Sciences of the USA 1990 87 9843-9847.
49. King JA, Marker PC, Seung KJ & Kingsley DM. BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Developmental Biology 1994 166 112-122.
50. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR. Lee A & Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. Journal of Cellular Biology 1994 126 1595-1609.
51. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK & Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGP-beta family. EMBO Journal 1990 9 2085-2093.
52. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H. Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Özkaynak K, Oppermann H & Rueger DC. Recombinant human osteogenic protein-1 (hOP-1) induces new hone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. Journal at Biological Chemistry 1992 267 20352-20362.
53. Ozkaynak E, Schnegelsherg PN, Jin DE, Clifford GM, Warren FD, Drier EA & Oppermann H. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. Journal of Biological Chemistry 1992 267 25220-25227.
54. Celeste AJ, Song JJ, Cox K, Rosen V & Wozney JM. Bone morphogenetic protein-9, a new member of the TGF beta superfamily. Journal of Bone and Mineral Research 1994 9 136.
55. Celeste AJ, Ross JL, Yamaji N & Wozney JM. The molecular cloning of human bone morphogenetic proteins-10, -11 and-12, three new members of the transforming growth factor-superfamily. Journal of Bone and Mineral Research 1995 10 S336.
56. Inada M, Katagiri T, Akiyama S, Namika M, Komaki M, Yamaguchi A, Kamoi K, Rosen V & Suda T. Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochemical and Biophysical Research Comunications 1996 222 317-322.
57. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM & Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGP-beta superfamily. Nature 1994 368 639-643.
58. Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E. Nove J. Song JJ, Wozney JM & Rosen V. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7. members of the TGP-beta gene family. Journal of Clinical Investigation 1997 100 321-330.
59. Dube JL & Celeste AJ. Human bone morphogenetic protein-15, a new member of the transforming growth factor beta superfamily. Journal of Bone and Mineral Research 1996 11 S382.
60. Cunningham NS, Jenkins NA, Gilbert DJ, Copeland NG, Reddi AH & Lee SJ. Growth/differentiation factor-10: a new member of the transforming growth factor-beta superfamily related to bone morphogenetic protein-3. Growth Factors 1995 12 99-109.
61. Takuwa Y, Ohse C, Wang EA, Wozney JM & Yamashita K, Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochemical and Biophysical Research Communications 1991 174 96-101.
62. Holbauer LC & Heufelder AE. Updating the metalloprotease nomenclature: bone morphogenetic protein 1 identified as procollagen C proteinase. European Journal of Endocrinology 1996 135 35-36.
63. Asahina I, Sampath TK, Nishimura I & Hauschka PV. Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. Journal of Cellular Biology 1993 123 921-933.
64. Maliakal JC, Asahina I, Hauschka PV & Sampath TK. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors 1994 11 227-234.
65. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V. Wang EA, Tanaka H, Omura S & Suda T. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochemical and Biophysical Research Communications 1990 172 295-299.
66. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T & Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. Journal of Cellular Biology 1991 113 681-687.
67. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS & Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Developmental Biology 1994 161 218-228.
68. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM & Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992 130 1318-1324.
69. Kim KJ, Itoh T & Kotake S. Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials. Journal of Biomedical Materials Research 1997 35 279-285.
70. Fromigue O. Marie PJ & Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. Journal of Cellular Biochemistry 1998 68 411-426.
71. Amedee J, Bareille R, Rouais F, Cunningham N, Reddi H & Harmand MF. Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. Differentiation 1994 58 157-164.
72. Groeneveld HHJ. Osteogenic protein-1 in human bone regeneration. Thesis, Vrije Universiteit, Amsterdam 1999.
73. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM. Rosen V & Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines. ST2 and MC3T3-G2/PA6. Biochemical and Biophysical Research Communications 1996 220 366-371.
74. Li IW, Cheifetz S, McCulloch CA, Sampath KT & Sodek J. Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific. Journal of Cellular Physiology 1996 169 115-125.
75. Shibano K, Watanabe J, Iwamoto M, Ogawa R & Kanamura S. Culture of stromal cells derived from medullary cavity of human long bone in the presence of 1,25-dihydroxyvitamin D3, recombinant human bone morphogenetic protein-2, or ipriflavone. Bone 1998 22 251-258.
76. Jortikka L, Laitinen M, Wiklund J, Lindholm TS & Marttinen A. Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins. Life Sciences 1998 62 2359-2368.
77. Katagiri T, Akiyama S, Namiki M, Komaki M, Yamaguchi A, Rosen V, Wozney JM, Fujisawa-Sehara A & Suda T. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Experimental Cell Research 1997 230 342-351.
78. Katagiri T. Yamaguchi A. Komaki M, Abe E. Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A & Suda T. Bone morphogenetic prolein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Journal of Cellular Biology 1994 127 1755-1766.
79. Knutsen R, Wergedal JE, Sampath TK, Baylink DJ & Mohan S. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochemical and Biophysical Research Communications 1993 194 1352-1358.
80. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A, Doty SB, Glaser D & Rosen VM. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. Journal of Orthopaedic Research 1995 13 357-367.
81. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dijke P & Sakou T. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998 22 605-612.
82. Boyan BD, Schwartz Z, Swain LD, Khare AG, Heckman JD, Ramirez V, Peters P & Carnes DL Jr. Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen, and alkaline phosphatase in nonunion cell cultures. Clinical Orthopaedics and Related Research 1992 278 286-304.
83. Mayer H, Scutt AM & Ankenbauer T. Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins-2 to -7 on DNA synthesis in primary bone-forming cells and identification of BMP-2/4 receptor. Calcified Tissue International 1996 58 249-255.
84. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM & Nanes MS. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 1996 137 3401-3407.
85. Hughes FJ, Collyer J, Stanfield M & Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995 1 36 2671-2677.
86. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA & Wozney JM. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 1996 13 291-300.
87. Hazama M, Aono A, Ueno N & Fujisawa Y. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochemical and Biophysical Research Communications 1995 209 859-866.
88. Aono A. Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S & Fujisawa Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochemical and Biophysical Research Communications 1995 210 670-677.
89. Kusumoto K, Bessho K, Fujimura K, Akioka J, Ogawa Y & Iizuka T. Comparison of ectopic osteoinduction in vivo by recombinant human BMP-2 and recombinant Xenopus BMP-4/7 heterodimer. Biochemical and Biophysical Research Communications 1997 239 575-579.
90. Yamashita H, Ten Dijke P, Heldin CH & Miyazono K. Bone morphogenetic protein receptors. Bone 1996 19 569-574.
91. Kretzschmar M & Massague J. SMADs: mediators and regulators of TGF-beta signaling. Current Opinion in Genetics and Development 1998 8 103-111.
92. Baker JC & Harland RM. From receptor to nucleus: the Smad pathway. Current Opinion in Genetics and Development 1997 7 467-473.
93. Padgett RW, Cho SH & Evangelista C. Smads are the central component in transforming growth factor-beta signaling. Pharmacology and Therapeutics 1998 78 47-52.
94. Graft JM, Bansal A & Melton DA. Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily. Cell 1996 85 479-487.
95. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG & Ron E. Recombinant human hone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats, Journal of Biomedical Materials Research 1994 28 1127-1158.
96. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM & Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. Journal of Bone and Joint Surgery American Volume 1992 74 659-670.
97. Kirker-Head CA, Gerhart TN, Schelling SH, Hennig GE, Wang E & Holtrop ME. Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clinical Orthopaedics and Related Research 1995 318 222-230.
98. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME & Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Archives of Otolaryngology: Head and Neck Surgery 1991 117 1101-1112.
99. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamarter RB & Dawson EG. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996 21 2115-2122.
100. Zegzula HD, Buck DC, Brekke J, Wozney JM & Hollinger JO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). Journal of Bone and Joint Surgery. American Volume 1997 79 1778-1790.
101. Lee SC, Shea M, Battle MA, Kozitza K, Ron E, Turek T, Schaub RG & Hayes WC. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. Journal of Biomedical Materials Research 1994 28 1149-1156.
102. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC & Whitecloud TS3. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. Journal of Bone and Joint Surgery, American Volume 1994 76 827-838.
103. Cook SD, Baffes GC, Wolfe MW, Sampath TK & Rueger DC, Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clinical Orthopaedics and Related Research 1994 301 302-312.
104. Cook SD, Wolfe MW, Salkeld SL & Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. Journal Bone and Joint Surgery, American Volume 1995 77 734-750.
105. Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC & Reddi AH. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1. bone morphogenetic protein-7). Growth Factors 1996 13 273-289.
106. Stevenson S, Cunningham N, Toth J, Davy D & Reddi AH. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. Journal of Bone and Joint Surgery. American Volume 1994 76 1676-1687.
107. Cook SD, Salkeld SL & Rueger DC. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites. Journal of Oral Implantology 1995 21 281-289.
108. Marglin MD, Cogan AG, Taylor M, Buck D, McAllister TN, Toth C & McAllister B. Maxillary sinus augmentation in the non-human primate: a comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. Journal of Periodontology 1998 69 911-919.
109. Nevins M, Kirker-Head C. Nevins M, Wozney JA, Palmer R & Graham D. Bone formation in the goal maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. International Journal of Periodontics and Restorative Dentistry 1996 16 8-19.
110. Postlethwaite AE, Raghow R, Stricklin C, Ballou L & Sampath TK. Osteogenic protein-1, a bone morphogenic protein member of the TGF-beta superfamily, shares chemotactic but not fibrogenic properties with TGF-beta. Journal of Cellular Physiology 1994 161 562-570.
111. Cunningham NS, Paralkar V & Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proceedings of the National Academy of Sciences of the USA 1992 89 11740-11744.
112. Lind M, Eriksen EF & Bunger C. Bone morphogenelic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 1996 18 53-57.
113. Urist MR, Sato K, Brownell AG, Malinin TI, Lietze A, Huo YK, Prolo DJ, Oklund S, Finerman GA & DeLange RJ. Human bone morphogenctic protein (hBMP). Proceedings of the Society for Experimental Biology and Medicine 1983 173 194-199.
114. Linde A & Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in rats. Calcified Tissue International 1995 56 549-553.
115. Yoshida K, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y & Iizuka T. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study, Journal of Craniomaxillofacial Surgery 1998 26 112-115.
116. Hanada K, Dennis JE, & Caplan Al. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Journal of Bone and Mineral Research 1997 12 1606-1614.
117. Wang JS & Aspenberg P. Basic fibroblast growth factor and bone induction in rats. Acta Orthopaedica Scandinavica 1993 64 557-561.
118. Ono I, Inoue M & Kuboki Y. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by prostaglandin E1. Bone 1996 19 581-588.
119. Ripamonti U, Duneas N, Van Den Heever B, Bosch C & Crooks J. Re-combinant transforming growth factor-beta 1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation, Journal of Bone and Mineral Research 1997 12 1584-1595.
120. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I & Wang EA. Growth factors influencing bone development. Journal of Cell Science 1991 13 149-156.
121. Gitelman SE, Kirk M, Ye JQ, Filvaroff EH, Kahn AJ & Derynck R. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth and Differentiation 1995 6 827-856.
122. Urist MR, Lietze A & Dawson K. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clinical Orthopaedics and Related Research 1984 187 277-280.
123. Sampath TK & Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proceedings of the National Academy of Sciences of the USA 1981 78 7599-7603.
124. Urist MR & Strates BS. Bone morphogenetic protein, Journal of Dental Research 1971 50 1392-1406.
125. Rao KP. Recent developments of collagen-based materials for medical applications and drug delivery systems, Journal of Biomaterials Science, Polymer Edition 1995 7 623-645.
126. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 1997 1895-105.
127. Cole BJ, Bostrom MP, Pritchard TL, Sumner DR, Tomin E. Lane JM & Weiland AJ. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clinical Orthopaedics and Related Research 1997 345 219-228.
128. Ripamonti U, Ma S & Reddi AH. The critical role of geometry of porous hydroxyapatile delivery system in induction of bone by osteogenin, a bone morphogenetic protein. Matrix 1992 12 202-212.
129. Urist MR, Nilsson O, Rasmussen J, Hirota W, Lovell T, Schmalzreid T & Finerman GA. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clinical Orthopaedics and Related Research 1987 214 295-304.
130. Yamazaki Y, Oida S, Akimoto Y & Shioda S. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris. Clinical Orthopaedics and Related Research 1988 234 240-249.
131. Hench LL. Bioactive glasses mechanisms of bioactive bonding. [web page] http://www.bg.ic.ac.uk/lectures/heneh/Bioglass/ cal3.htm
132. Hollinger JO & Leong K. Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 1996 17 187-194.
133. Rokkanen P, Bostman O, Vainionpaa S, Vihtonen K, Tormala P, Laiho J, Kilpikari J & Tamminmaki M. Biodegradable implants in fracture fixation: early results of treatment of fractures of the ankle. Lancet 1985 1 1422-1424.
134. DeLustro F, Dasch J, Keefe J & Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clinical Orthopaedics and Related Research 1990 260 263-279.
135. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. Journal of Bone and joint Surgery, American Volume 1995 77 1742-1754.
136. Buck BE, Resnick L., Shah SM & Malinin TI. Human immunodeficiency virus cultured from bone. Implications for transplantation. Clinical Orthopaedics and Related Research 1990 251 249-253.
137. Nimb L, Jensen JS & Gotfredsen K. Interface mechanics and histomorphometric analysis of hydroxyapatite-coated and porous glass-ceramic implants in canine bone. Journal of Biomedical Materials Research 1995 29 1477-1482.
138. Matsuda M, Kita S, Takekawa M, Ohtsubo S & Tsuyama K. Scanning electron and light microscopic observations on the healing process after sintered bone implantation in rats. Histology and Histopathology 1995 10 673-679.
139. Einhorn TA, Majeska RJ, Rush EB, Levine PM & Horowitz MC. The expression of cytokine activity by fracture callus. Journal of Bone and Mineral Research 1995 10 1272-1281.
140. Santavirta S, Konttinen YT, Nordstrom D, Makela A, Sorsa T, Hukkanen M & Rokkanen P. Immunologic studies of nonunited fractures. Acta Orthopaedica Scandinavica 1992 65 579-586.
141. Andrew JG, Andrew SM, Freemont AJ & Marsh DR. Inflammatory cells in normal human fracture healing. Acta Orthopaedica Scandinavica 1994 65 462-466.
142. Mahy PR & Urist MR. Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B. Clinical Orthopaedics and Related Research 1988 237 236-244.
143. Fujimori Y, Nakamura T, Ijiri S, Shimizu K & Yamamuro T, Heterotopic bone formation induced by bone morphogenetic protein in mice with collagen-induced arthritis. Biochemical and Biophysical Research Communications 1992 186 1362-1367.
144. Pearson CM & Wood FD. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. 1. General clinical and pathological characteristics and some modifying factors. Arthritis and Rheumatism 1959 2 440-459.
145. Baron R & Saffar JL. Bone remodeling during experimental periodontal disease in the golden hamster: a quantitative study. Journal of Periodontal Research 1978 13 309-315.
146. Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A & Lindholm TC. Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass and tricalcium phosphate implanted in sheep diaphyseal defects. Biomaterials 1995 16 1175-1179.
147. Meikle MC, Papaioannou S, Ratledge TJ, Speight PM, Watt-Smith SR, Hill PA & Reynolds JJ. Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials 1994 15 513-521.
148. Verheyen CC, de Wijn JR, van Blitterswijk CA, de Groot K & Rozing PM. Hydroxylapatite/(poly)L-lactide composites: an animal study on push-out strengths and interface histology. Journal of Biomedical Materials Research 1993 27 433-444.
149. Shi S, Kirk M & Kahn AJ. The role of type I collagen in the regulation of the osteoblast phenotype. Journal of Bone and Mineral Research 1996 11 1139-1145.
150. Muthukumaran N, Ma S & Reddi AH. Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Collagen Related Research 1988 8 433-441.
151. Otto TE, Klein CPAT. Patka P & de Vries R. Intramedullary bone formation after polylactic acid wire implantation. Journal of Materials Science: Materials in Medicine 1994 5 407-410.
152. Otto TE, Klein-Nulend J, Patka P, Burger EH & Haarman HJ. Effect of (poly )-L-lactic acid on the proliferation and differentiation of primary bone cells in vitro. Journal of Biomedical Materials Research 1996 32 513-518.
153. Hollinger JO. Preliminary report on the osteogenic potential of a biodegradable copolymer of polylactide (PLA) and polyglycolide (PGA). Journal of Biomedical Materials Research 1983 17 71-82.
154. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 1996 17 31-35.
155. Winn SR, Uludag H & Hollinger JO. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Advanced Drug Delivery Reviews 1998 31 303-318.
156. Ijiri S, Nakamura T, Fujisawa Y, Hazama M & Komatsudani S. Ectopic bone induction in porous apatite-wollastonite-containing glass ceramic combined with bone morphogenetic protein. Journal of Biomedical Materials Research 1997 35 421-432.
157. Takaoka K, Nakahara H, Yoshikawa H, Masuhara K, Tsuda T & Ono K. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clinical Orthopaedics and Related Research 1988 234 250-254.
158. Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietze A, Tempst P, Hunkapiller M & DeLange RJ. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proceedings of the National Academy of Sciences of the USA 1984 81 371-375.
159. Oda S, Kinoshita A, Higuchi T, Shizuya T & Ishikawa I. Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Medical and Dental Sciences 1997 44 53-62.
160. Gao T, Lindholm TS, Marttinen A & Urist MR. Composites of bone morphogenetic protein (BMP) and type IV collagen, coralderived coral hydroxyapatile. and tricalcium phosphate ceramics. International Orthopaedics 1996 20 321-325.
161. Ono I, Ohura T, Murata M, Yamaguchi H, Ohnuma Y & Kuboki Y. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plastic and Reconstructive Surgery 1992 90 870-879.
162. Meikle MC, Mak WY, Papaioannou S, Davies EH, Mordan N & Reynolds JJ. Bone-derived growth factor release from poly(alphahydroxy acid) implants in vitro. Biomaterials 1993 14 177-183.
163. Asahina I, Watanabe M, Sakurai N, Mori M & Enomoto S. Repair of bone defect in primate mandible using a bone morphogenetic protein (BMP)-hydroxyapatite-collagen composite. Journal of Medical and Dental Sciences 1997 44 63-70.
164. Kenley R, Marden L, Turek T, Jin L, Ron E & Hollinger JO. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Biomedical Materials and Research 1994 28 1139-1147.
165. Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M, Nagai N, Dohi Y & Ohgushi H. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. Journal of Biomedical Materials and Research 1998 39 190-199.
166. Hollinger JO, Schmitz JP, Mark DE & Scyfer AE. Osseous wound healing with xenogeneic hone implants with a biodegradable carrier. Surgery 1990 107 50-54.
167. van Heden SP & Ripamonti U. Bone differentiation in porous hydroxyapatite in baboons is regulated by the geometry of the substratum: implications for reconstructive craniofacial surgery. Plastic and Reconstructive Surgery 1994 93 959-966.
168. Tsuruga E, Takita H, Itoh H, Wakisaka Y & Kuboki Y. Fore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. Journal of Biochemistry (Tokyo) 1997 121 317-324.
169. Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM & Wikesjo UM. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. International Journal of Periodontics and Restorative Dentistry 1996 16 524-537.
170. Helder MN, Ozkaynak E, Sampath UT, Luyten FP, Oppermann H & Vukicevic S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. Journal of Histochemistry and Cytochemistry 1995 43 1035-1044.
171. Vukicevic S, Kopp JB, Luyten FP & Sampath TK. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proceedings of the National Academy of Sciences of the USA 1996 93 9021-9026.
172. Perides G, Jensen FE, Edgecomb P, Ruegerf DC & Charness ME. Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia. Neuroscience Letters 1995 187 21-24.
173. Kawamata T, Ren J, Chan TCK, Charette M & Finklestein SP. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. NeuroReport 1998 9 1441-1445.
174. Vukicevic S, Basic V, Rogic D, Basic N, Shih M-S, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A & Sampath TK. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. Journal of Clinical Investigation 1998 102 202-214.
175. Sigurdsson TJ, Lee MB, Kubota K, Turck TJ, Wozney JM & Wikesjö UME. Peridontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances perindontal regeneration. Journal of Periodontology 1995 66 131-138.
176. Giannobile WV, Ryan S, Shih M-S, Su DL, Kaplan PL, & Chan TCK. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. Journal of Periodontology 1998 69 129-137.